KELASH BAJAJ MD NPI 1518220771

NPI Information

  • NPI: 1518220771
  • Provider Name: KELASH BAJAJ, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 500 W 3RD ST
    ODESSA, TX
    ZIP 79761
  • Phone: (432) 335-8275

Map and Directions

Get Directions

NPI Details

Kelash Bajaj, MD is a hematology and oncology internal medicine in Odessa, TX with 20 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Kelash Bajaj, MD NPI is 1518220771. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

500 W 3RD ST
ODESSA, TX
ZIP 79761
Phone: (432) 335-8275
Fax: (432) 334-0687

The NPI 1518220771 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Albumin (protein) level (HCPCS:82040)
  • Bilirubin level, total (HCPCS:82247)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Unclassified drugs (HCPCS:J3490)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Urinalysis, manual test (HCPCS:81002)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Blood creatinine level (HCPCS:82565)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 6/21/2012 and was last updated on 11/4/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyQ3212TEXASYes
2207R00000XInternal Medicine0101123456VIRGINIANo

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1381708201MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.